These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


428 related items for PubMed ID: 9576751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages.
    Lima MF, Zhang Y, Villalta F.
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1067-76. PubMed ID: 9449540
    [Abstract] [Full Text] [Related]

  • 5. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
    Aquaro S, Menten P, Struyf S, Proost P, Van Damme J, De Clercq E, Schols D.
    J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
    [Abstract] [Full Text] [Related]

  • 6. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G, Bovolenta C, Rigamonti L, Borghi I, Altare F, Jouanguy E, Forni G, Casanova JL, Sherry B, Mengozzi M, Trinchieri G, Poli G, Gerosa F, Novelli F.
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
    Elliott MB, Tebbey PW, Pryharski KS, Scheuer CA, Laughlin TS, Hancock GE.
    J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines.
    Ito Y, Grivel JC, Chen S, Kiselyeva Y, Reichelderfer P, Margolis L.
    J Infect Dis; 2004 Feb 01; 189(3):506-14. PubMed ID: 14745709
    [Abstract] [Full Text] [Related]

  • 11. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
    Trkola A, Paxton WA, Monard SP, Hoxie JA, Siani MA, Thompson DA, Wu L, Mackay CR, Horuk R, Moore JP.
    J Virol; 1998 Jan 01; 72(1):396-404. PubMed ID: 9420238
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of CCR5 expression by IL-12 through induction of beta-chemokines in human T lymphocytes.
    Wang J, Guan E, Roderiquez G, Norcross MA.
    J Immunol; 1999 Dec 01; 163(11):5763-9. PubMed ID: 10570258
    [Abstract] [Full Text] [Related]

  • 13. Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production.
    Yang JY, Togni M, Widmer U.
    Cytokine; 1999 Jan 01; 11(1):1-7. PubMed ID: 10080873
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological characterization of the chemokine receptor, CCR5.
    Mueller A, Mahmoud NG, Goedecke MC, McKeating JA, Strange PG.
    Br J Pharmacol; 2002 Feb 01; 135(4):1033-43. PubMed ID: 11861332
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Soluble CD40 ligand induces beta-chemokine production by macrophages and resistance to HIV-1 entry.
    di Marzio P, Mariani R, Lui R, Thomas EK, Landau NR.
    Cytokine; 2000 Oct 01; 12(10):1489-95. PubMed ID: 11023663
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.